Over the past few weeks, one "clinical stage" pharma firm after another has seen its stock price rise and plummet on rumors about who has the...
Tekmira Pharma (Nasdaq: TKMR) stock surged more than 25% to $26.50 Wednesday after the CDC confirmed Tuesday the first Ebola...
Dow Jones today, October 1, 2014: The Dow Jones Industrial Average fell 28 points Tuesday as both domestic and global...
Stock market close, Aug. 8, 2014: The DJIA and other U.S. markets soared on Friday after positive...
Tekmira Pharmaceuticals Corp. (Nasdaq: TKMR) stock surged some 20% to $17.23 Friday after an update on its Ebola treatment.
The U.S....
Tekmira Pharmaceutical (Nasdaq: TKMR) is on a roller coaster ride as investors bet on its chances to be the first drug to successfully develop...
